Home›Search›Immunopathologia Persa

Immunopathologia Persa

Nickan Research Institute · Iran · Est. 2016

ISSN2423-8015eISSN2423-8015

SJR Q4✓ WOS ESCI✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS ESCI56

✓ Corroboration (1 more)+6

⚠ Withdrawn from DOAJ-15

Total47

Third-party records · how this is calculated · Report an error →

Removed from DOAJ (2021-10-05). DOAJ's stated reason: Journal not adhering to Best practice. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

120

days submission → published

measured · last 20 articles · accept 85d

SJR Rank

Bottom 25%

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q4. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.232

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.197

Total Worksi

370

Total Citationsi

1,021

2yr Mean Citednessi

0.87

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Immunopathologia Persa is an international peer-reviewed journal that includes the study of the pathology of organ systems, organisms, or diseases with respect to the immune system, immunity, and immune responses. The journal also covers immunologic mechanisms of injury and major autoimmune diseases.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionIran

Primary LanguageEnglish

1st Year Published2016

Annual Volume~ 45 articles / year

StatusActive (last: 2025)

Total Publications370

Publisher OrgNickan Research Institute

Region🌍 Global South

OA Since2015

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Nickan Research Institute

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2423-8015 / 2423-8015

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

218

2019

226

2020

203

2021

138

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Endocrinology, Diabetes and MetabolismQ4

HematologyQ4

ImmunologyQ4

Immunology and Microbiology (miscellaneous)Q4

Subject Classification

Web of Science Categories

Immunology

Scopus Categories

HematologyImmunologyImmunology and Microbiology (miscellaneous)Endocrinology, Diabetes and Metabolism

Research Topics (OpenAlex)

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchLiver Disease Diagnosis and TreatmentRenal Diseases and GlomerulopathiesAntibiotic Resistance in BacteriaPregnancy and preeclampsia studiesRespiratory Support and MechanismsPancreatitis Pathology and TreatmentInflammatory Biomarkers in Disease Prognosis

Frequently asked questions about Immunopathologia Persa

Is Immunopathologia Persa a predatory journal?

Immunopathologia Persa was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal not adhering to Best practice" (2021-10-05). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Immunopathologia Persa?

Immunopathologia Persa is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.87.

Is Immunopathologia Persa indexed in Scopus and Web of Science?

Immunopathologia Persa is indexed in Web of Science, Scopus.